Overview

Clinical Trial, Open-label, Randomised, in Order to Compare the Quality of Life for Those VIH+ Patients That Start With Monotherapy on LPV/r Tablets Vs. Triple Therapy With a Boosted Protease Inhibitor

Status:
Completed

Trial end date:
2011-12-01

Target enrollment:

Participant gender:

Summary

The Study will help to compare the Quality of Life for those HIV patients that are on monotherapy with LPV/r Vs. triple therapy with a boosted protease inhibitor

Phase:

Phase 4

Details

Lead Sponsor:

Sociedad Andaluza de Enfermedades Infecciosas

Treatments:

HIV Protease Inhibitors
Lopinavir
Protease Inhibitors
Ritonavir